Trade Report: The Stericycle Inc. (SRCL) to Post FY2016 Earnings of $4.74 Per Share, William Blair Forecasts

The Stericycle Inc. (SRCL) to Post FY2016 Earnings of $4.74 Per Share, William Blair Forecasts

Stericycle Inc. (NASDAQ:SRCL) – Analysts at William Blair upped their FY2016 earnings per share estimates for shares of Stericycle in a note issued to investors on Thursday. William Blair analyst R. Daniels now anticipates that the firm will post earnings per share of $4.74 for the year, up from their prior estimate of $4.68. William Blair also issued estimates for Stericycle’s Q4 2016 earnings at $1.20 EPS and FY2017 earnings at $4.60 EPS.

Several other research analysts also recently commented on SRCL. Zacks Investment Research raised Stericycle from a “sell” rating to a “hold” rating in a research note on Monday, July 4th. Jefferies Group restated a “buy” rating and set a $140.00 price target on shares of Stericycle in a report on Monday, July 18th. Imperial Capital cut Stericycle from an “in-line” rating to an “underperform” rating and reduced their price target for the stock from $100.00 to $93.50 in a report on Friday, July 29th. Wellington Shields cut Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Finally, Macquarie started coverage on Stericycle in a report on Thursday, August 25th. They set a “neutral” rating and a $96.00 price target on the stock. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $98.58.

Shares of Stericycle (NASDAQ:SRCL) opened at 79.73 on Monday. The firm’s 50-day moving average is $77.86 and its 200 day moving average is $94.04. Stericycle has a one year low of $72.89 and a one year high of $128.94. The firm has a market capitalization of $6.82 billion, a P/E ratio of 28.98 and a beta of 0.20.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, October 27th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.17 by $0.07. The firm had revenue of $890.10 million for the quarter, compared to the consensus estimate of $899.87 million. Stericycle had a net margin of 7.52% and a return on equity of 15.41%. The business’s quarterly revenue was up 23.9% on a year-over-year basis. During the same period last year, the company posted $1.08 EPS.

In other news, Director Rodney F. Dammeyer sold 10,188 shares of the company’s stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total transaction of $871,074.00. Following the transaction, the director now directly owns 10,188 shares of the company’s stock, valued at $871,074. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John P. Schetz sold 1,398 shares of the company’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the transaction, the executive vice president now directly owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. Company insiders own 3.30% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Capstone Asset Management Co. raised its position in shares of Stericycle by 0.3% in the third quarter. Capstone Asset Management Co. now owns 7,633 shares of the company’s stock worth $612,000 after buying an additional 20 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock worth $149,000 after buying an additional 41 shares during the last quarter. Genesee Valley Trust Co. raised its position in shares of Stericycle by 1.0% in the second quarter. Genesee Valley Trust Co. now owns 4,511 shares of the company’s stock worth $470,000 after buying an additional 43 shares during the last quarter. Spero Smith Investment Advisers Inc. OH raised its position in shares of Stericycle by 0.3% in the second quarter. Spero Smith Investment Advisers Inc. OH now owns 16,883 shares of the company’s stock worth $1,758,000 after buying an additional 50 shares during the last quarter. Finally, Ameritas Investment Partners Inc. raised its position in shares of Stericycle by 1.7% in the second quarter. Ameritas Investment Partners Inc. now owns 3,091 shares of the company’s stock worth $322,000 after buying an additional 53 shares during the last quarter. 92.76% of the stock is currently owned by institutional investors.

Stericycle Company Profile

Related posts

Leave a Comment